Syneron Medical (ELOS) Preliminary Q4 Revenue Tops Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Syneron Medical (ELOS) Preliminary Q4 Revenue Tops Views

Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue

January 11, 2016 4:05 PM EST

IRVINE, Calif., Jan. 11, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today provided preliminary unaudited fourth quarter 2015 revenue results in conjunction with planned meetings January 11-14 surrounding the annual J.P. Morgan Healthcare Conference in San Francisco. Total revenue for the fourth quarter 2015 is expected to be in the range of $78 to $79 million, compared to $74.1 million in the fourth quarter 2014, up approximately 5% to 7% year-over-year, or approximately 9% to 10% in constant currency.

Amit Meridor, Chief Executive... More